[home]
[thesaurus]
Click Here to return To Results
Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII?
Stroke 40:833-840, Mayer,S.A.,et al, 2009
See this aricle in Pubmed
Article Abstract
A prospective trial would be needed to determine whether younger patients with ICH without extensive bleeding at baseline can benefit from 80 ?g/kg of rFVLLa given within 2.5 hrs of symptom onset.
Related Tags
(click to filter results - removes previous filter)
cerebrovascular accident,young adult
FAST trial
hemostatic therapy
intracerebral hemorrhage
recombinant activated factor VII
treatment of neurologic disorder
Click Here to return To Results